Corpus Intelligence IC Memo — KINDRED HOSPITAL INDIANAPOLIS NORTH 2026-04-26 11:53 UTC
IC Memo — KINDRED HOSPITAL INDIANAPOLIS NORTH
Investment Committee Memorandum | IN | 45 beds | Grade D | EBITDA uplift $1.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KINDRED HOSPITAL INDIANAPOLIS NORTH

CCN 152013 | MARION, IN | 45 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

KINDRED HOSPITAL INDIANAPOLIS NORTH is a 45-bed community hospital in MARION, IN with $16.0M in net patient revenue and a -11.7% operating margin. The hospital serves a payer mix of 30.4% Medicare, 0.0% Medicaid, and 69.6% commercial.

Thesis: Turnaround. Our ML models identify $1.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.7% to -4.4% (+736bps).

Net Revenue HCRIS$16.0M
Current EBITDA COMPUTED$-1.9M
Operating Margin COMPUTED-11.7%
Occupancy HCRIS42.7%
Revenue / Bed COMPUTED$356K
Net-to-Gross HCRIS34.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
88
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -11.7% places it below the state median. Among 88 size-comparable peers (22-90 beds), the median margin is -1.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-90), prioritizing same-state peers. 88 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KINDRED HOSPITAL INDIANAPOLIS (Target)IN45$16.0M-11.7%
INDIANA ORTHOPAEDIC HOSPITAL LIN38$196.8M31.2%
LAPORTE HOSPITALIN74$192.4M19.3%
SCHNECK MEDICAL CENTERIN60$184.2M-0.8%
ORTHOPAEDIC HOSPT.AT PARKVIEWIN37$175.7M36.8%
LUTHERAN MUSCULOSKELETAL CENTEIN39$168.9M25.0%
WITHAM MEMORIAL HOSPITALIN50$158.5M-11.6%
FRANCISCAN HEALTH MOORESVILLEIN80$157.3M26.2%
MAJOR HOSPITALIN46$156.9M-9.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$336K+210bp18mo
Cost to Collect4.5%2.5%$320K+200bp12mo
Denial Rate Reduction12.0%6.5%$317K+198bp12mo
A/R Days Reduction5200.0%3800.0%$195K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$336K
Cost to Collect
$320K
Denial Rate Reduction
$317K
A/R Days Reduction
$195K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.2M
Current EBITDA$-1.9M
+ RCM Uplift+$1.2M
Pro Forma EBITDA$-700K
Current Margin-11.7%
Pro Forma Margin-4.4%
WC Released (1x)$614K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.9M$-606K0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.9M$-1.6M0.00x-100.0%
Bull Case9.0x11.0x$-2.6M$1.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.6M$700K0.00x-100.0%
Bear Case11.0x10.0x$-3.2M$-5.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.2M$-7.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 88 hospitals with 22-90 beds
  • Same-state prioritization (n=89)
  • Comp margins: P25=-12.1% / P50=-1.6% / P75=9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.